相关实验视频

Updated: Jul 10, 2025

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

针对癌症药物的地平线扫描的量身定制方法

Jennifer A Soon¹, Yat Hang To², Marliese Alexander³

¹Centre for Health Policy, Cancer Health Services Research, University of Melbourne, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.

Journal of cancer policy

|November 26, 2023

概括

地平线扫描 (HS) 系统地识别新兴疗法. 这种灵活的方法结合了多标准决策分析和Delphi轮,根据临床和消费者价值优先考虑癌症药物,预测高成本药物的流行.

科学领域:

卫生政策和制药管理
卫生技术评估卫生技术评估
瘤学药物评估瘤学药物评估

背景情况:

视界扫描 (HS) 对于识别新兴疗法以告知政策至关重要.
现有的HS方法需要灵活和针对特定环境的定制方法.
澳大利亚的制药预算面临着来自新高成本药物的压力.

研究的目的:

开发和测试一个敏捷的HS方法,整合多标准决策分析和Delphi轮.
到2025年,确定可能影响澳大利亚制药预算的癌症药物.
为了比较临床医生和消费者在癌症药物报销方面的优先事项.

主要方法:

形成了三种癌症类型的临床医生 (n=27) 和消费者 (n=7) 专家小组.
开发了六个优先级标准与消费者输入,使用分析层次过程 (AHP) 重量它们.
利用三轮Delphi调查对临床医生进行评分,通过数据库过确定候选药物.

主要成果:

在八周内完成了AHP和Delphi过程.
消费者优先考虑毒性和生活质量 (QoL) 而不是生存,而临床医生优先考虑生存.
在药用益处咨询委员会评估提交的药物中,HS发现了70%的药物,在药用益处咨询委员会评估后,HS发现了60%的药物.

结论:

开发的HS方法是高效的,灵活的,可以适应特定类型的疾病.
它有效地整合了临床和消费者观点,以根据增值来优先考虑药物.
该方法为医疗保健机构的全球适应提供了可重复的蓝图.

关键词:

生物医学生物医学癌症癌症癌症癌症结肠直肠癌是一种癌症.社区参与社区参与决策决策是做出决定的.医疗保健成本医疗保健成本卫生政策卫生政策健康优先事项卫生优先事项黑色素瘤是一种黑色素瘤.非小细胞肺癌是非小细胞肺癌.技术评估技术评估技术评估技术评估技术评估

更多相关视频

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...